Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Shoulder Pain
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: RCT among two groups,Masking: Double (Participant, Outcomes Assessor)Masking Description: Allocated participants, they do not know which group they would be in. Assessor do not know which group of participant that would perform.Primary Purpose: Treatment

Participation Requirements

Age
Between 25 years and 70 years
Gender
Both males and females

Description

Participants Age 25-50 years, male and female People who have a shoulder condition. (By measuring in the supine position, distance from the posterior aspect of acromion to the bed> 1 inch on both sides) People with moderate to severe neck and shoulder pain (VAS> 3) People who have to use their arms ...

Participants Age 25-50 years, male and female People who have a shoulder condition. (By measuring in the supine position, distance from the posterior aspect of acromion to the bed> 1 inch on both sides) People with moderate to severe neck and shoulder pain (VAS> 3) People who have to use their arms for work Overall more than 3 hours per day For attaching the tape, the researcher will prepare a replacement shirt in case the For the convenience of tape, the experimental group, trained by Certified Kinesio tape, attached the kinesio tape. Attaching the tape By using functional correction techniques, apply from the front of the acromion process to the spinous process T10 on both sides. Measurements The pressure of (average of peak force) of both arms (pounds) The pulling force (average of peak force) of both arms (pounds) Time of overhead endurance test (TMT) (seconds) Visual analog scale (VAS) The distance from the posterior aspect of acromion to the bed (inches) process of measuring the evaluation 3 times st after physical therapy treatment Before attaching the kinase tape nd evaluation period was 48 hours apart before the next treatment. rd evaluation period is 1 week apart.

Tracking Information

NCT #
NCT04346563
Collaborators
Not Provided
Investigators
Not Provided